Skip to main content
. 2017 Feb 21;8(15):24635–24643. doi: 10.18632/oncotarget.15601

Figure 6. Effects of IMB-1406 on the levels of Bax, Bcl-2 and caspase-3.

Figure 6

HepG2 cells were treated with IMB-1406 at 2 μM, 4 μM and 8 μM for 72 h. The cell lysates were collected and expression levels of Bax, Bcl-2 and caspase-3 were determined by western blot analysis. GADPH was used as internal control.